XGEN.DE vs. XSOE

Last updated Jun 5, 2026

XGEN.DE (Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C) and XSOE (WisdomTree Emerging Markets ex-State-Owned Enterprises Fund) are both exchange-traded funds - XGEN.DE is a Health & Biotech Equities fund tracking the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XSOE is a Emerging Markets Equities fund tracking the WisdomTree Emerging Markets ex-State-Owned Enterprises Index. Both are passively managed. Over the past 3 years, XGEN.DE returned 1.39%/yr vs 19.73%/yr for XSOE. At a 0.35 correlation, their price movements are largely independent. XGEN.DE charges 0.30%/yr vs 0.32%/yr for XSOE.

Performance

XGEN.DE vs. XSOE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

XGEN.DE is traded in EUR, while XSOE is traded in USD. To make them comparable, the XSOE values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, XGEN.DE achieves a -1.40% return, which is significantly lower than XSOE's 28.15% return.

XGEN.DE

• 1D: 3.92%
• 1M: 6.45%
• YTD: -1.40%
• 6M: -3.78%
• 1Y: 22.37%
• 3Y*: 1.39%
• 5Y*: —
• 10Y*: —

XSOE

• 1D: -1.14%
• 1M: 7.26%
• YTD: 28.15%
• 6M: 29.93%
• 1Y: 48.70%
• 3Y*: 19.73%
• 5Y*: 5.82%
• 10Y*: 10.26%

*Multi-year figures are annualized to reflect compound growth (CAGR)

XGEN.DE vs. XSOE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	-1.40%	7.38%	2.95%	-5.84%	-9.98%
XSOE WisdomTree Emerging Markets ex-State-Owned Enterprises Fund	28.15%	14.62%	14.09%	6.97%	-9.31%

Correlation

The correlation between XGEN.DE and XSOE is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.32
Correlation (3Y) Calculated over the trailing 3-year period	0.35
Correlation (All Time) Calculated using the full available price history since Jul 20, 2022	0.35

Return for Risk

XGEN.DE vs. XSOE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XGEN.DE

XGEN.DE Risk / Return Rank: 32
XGEN.DE Sharpe Ratio Rank: 35
XGEN.DE Sortino Ratio Rank: 36
XGEN.DE Omega Ratio Rank: 32
XGEN.DE Calmar Ratio Rank: 30
XGEN.DE Martin Ratio Rank: 26

XSOE

XSOE Risk / Return Rank: 79
XSOE Sharpe Ratio Rank: 81
XSOE Sortino Ratio Rank: 78
XSOE Omega Ratio Rank: 81
XSOE Calmar Ratio Rank: 78
XSOE Martin Ratio Rank: 78

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XGEN.DE vs. XSOE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) and WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	XGEN.DE	XSOE	Difference
Sharpe ratio: Return per unit of total volatility	1.23	2.64	-1.41
Sortino ratio: Return per unit of downside risk	1.85	3.53	-1.68
Omega ratio: Gain probability vs. loss probability	1.21	1.49	-0.28
Calmar ratio: Return relative to maximum drawdown	1.49	4.58	-3.10
Martin ratio: Return relative to average drawdown	3.61	16.45	-12.85
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XGEN.DE vs. XSOE - Sharpe Ratio Comparison

The current XGEN.DE Sharpe Ratio is 1.23, which is lower than the XSOE Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of XGEN.DE and XSOE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	XGEN.DE	XSOE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.23	2.64	-1.41
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.33	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.52	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.11	0.44	-0.54

Drawdowns

XGEN.DE vs. XSOE - Drawdown Comparison

The maximum XGEN.DE drawdown since its inception was -37.58%, which is greater than XSOE's maximum drawdown of -33.23%. Use the drawdown chart below to compare losses from any high point for XGEN.DE and XSOE.

Drawdown Indicators

	XGEN.DE	XSOE	Difference
Max Drawdown Largest peak-to-trough decline	-37.58%	-33.23%	-4.35%
Max Drawdown (1Y) Largest decline over 1 year	-14.99%	-10.68%	-4.31%
Max Drawdown (3Y) Largest decline over 3 years	-28.21%	-19.82%	-8.39%
Max Drawdown (5Y) Largest decline over 5 years	—	-30.18%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-33.22%	—
Current Drawdown Current decline from peak	-14.86%	-2.16%	-12.70%
Average Drawdown Average peak-to-trough decline	-19.44%	-13.43%	-6.01%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.19%	2.97%	+3.22%

Volatility

XGEN.DE vs. XSOE - Volatility Comparison

The current volatility for Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C (XGEN.DE) is 6.48%, while WisdomTree Emerging Markets ex-State-Owned Enterprises Fund (XSOE) has a volatility of 7.79%. This indicates that XGEN.DE experiences smaller price fluctuations and is considered to be less risky than XSOE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XGEN.DE	XSOE	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.48%	7.79%	-1.31%
Volatility (6M) Calculated over the trailing 6-month period	13.73%	15.82%	-2.09%
Volatility (1Y) Calculated over the trailing 1-year period	18.19%	18.55%	-0.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.66%	17.68%	+0.98%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.66%	19.90%	-1.24%

XGEN.DE vs. XSOE - Expense Ratio Comparison

XGEN.DE has a 0.30% expense ratio, which is lower than XSOE's 0.32% expense ratio.

Dividends

XGEN.DE vs. XSOE - Dividend Comparison

XGEN.DE has not paid dividends to shareholders, while XSOE's dividend yield for the trailing twelve months is around 1.29%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
XGEN.DE Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
XSOE WisdomTree Emerging Markets ex-State-Owned Enterprises Fund	1.29%	1.50%	1.44%	1.78%	2.53%	1.36%	1.02%	2.01%	1.56%	0.65%	1.43%	3.93%

Frequently Asked Questions

Can I hold both XGEN.DE and XSOE in my portfolio?

XGEN.DE and XSOE have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, XGEN.DE or XSOE?

On fees, XGEN.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, XGEN.DE or XSOE?

XGEN.DE is cheaper with a 0.30% expense ratio, compared with 0.32% for XSOE.

What is the main difference between XGEN.DE and XSOE?

XGEN.DE is categorized as Health & Biotech Equities, while XSOE is Emerging Markets Equities. XGEN.DE tracks MSCI ACWI IMI Genomic Innovation Select ESG Screened 100, while XSOE tracks WisdomTree Emerging Markets ex-State-Owned Enterprises Index. They also come from different issuers: Xtrackers and WisdomTree. Their fees differ too: 0.30% for XGEN.DE and 0.32% for XSOE.